Depression hinders HIV treatment protocols, but effective medication reverses that outcome. Kaiser Permanente published the information from the largest study of its kind in the Journal of Acquired Immune Deficiency Syndromes. It looked at 3,359 HIV-infected patients across the nation to measure the effects of depression – with and without selective anti-depression medication – on […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Digital Partnership, Silver Membership, Print & Digital, Print, Digital and The Transcript, Corporate Membership or Digital Monthly If you're already a member, sign in here.